Natixis’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-488,318
Closed -$104M 1210
2023
Q3
$104M Buy
488,318
+433,940
+798% +$86.7M 0.79% 16
2023
Q2
$10.5M Buy
54,378
+50,218
+1,207% +$9.98M 0.09% 187
2023
Q1
$842K Sell
4,160
-22,448
-84% -$3.6M 0.01% 551
2022
Q4
$3.42M Buy
26,608
+21,247
+396% +$2.74M 0.02% 446
2022
Q3
$734K Sell
5,361
-3,225
-38% -$525K ﹤0.01% 820
2022
Q2
$1.52M Buy
8,586
+5,932
+224% +$855K 0.01% 728
2022
Q1
$382K Sell
2,654
-1,101
-29% -$149K ﹤0.01% 1024
2021
Q4
$581K Sell
3,755
-423
-10% -$70.8K ﹤0.01% 1007
2021
Q3
$709K Buy
+4,178
New +$650K ﹤0.01% 953
2021
Q2
Sell
-51,760
Closed -$7.19M 1166
2021
Q1
$7.19M Sell
51,760
-14,373
-22% -$2.32M 0.02% 438
2020
Q4
$11.6M Buy
+66,133
New +$12.3M 0.04% 358
2018
Q4
Sell
-16,698
Closed -$1.29M 857
2018
Q3
$1.29M Buy
+16,698
New +$1.23M 0.01% 539

Other funds holding SGEN

Natixis's SGEN Position: Q4 2023 in Review

Natixis sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 488,318 shares — an estimated $104M sold.

Natixis first reported a position in SGEN in Q3 2018 and held it in 12 quarters. The position peaked at $104M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Natixis reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Natixis sold 488,318 Seagen Inc. Common Stock shares in Q4 2023, an estimated $104M.
  • Natixis first reported a position in Seagen Inc. Common Stock in Q3 2018 and held it in 12 quarters.
  • Natixis's Seagen Inc. Common Stock position peaked at $104M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Natixis's 13F filing for Q4 2023, filed 13 Feb 2024.